Thermosome

Thermosome is a drug development company that utilizes a proprietary tumor targeting concept to increase local drug concentrations and stimulate immune responses. The company is currently developing THE001, a thermosensitive liposomal formulation, for the treatment of locally advanced soft tissue sarcoma. Its technology aims to improve clinical treatment efficacy by enabling intravascular drug release specifically at the tumor site.